Personalized medicine: applying 'omics' to lung fibrosis - Test2 - elhamkhani - TriplyDB

Personalized medicine: applying 'omics' to lung fibrosis

Personalized medicine: applying 'omics' to lung fibrosis

http://www.wikidata.org/entity/Q26866919

about

The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course.Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.Molecular biomarkers in interstitial lung diseases.Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications.Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.Delving Deep into the Proteome of Lung Fibrosis Brings Plasma Cells to the Surface.

P2860

Q33901590-E74F20A5-CBF9-44C4-91D4-72AAA0AAD747 Q35239965-770A2821-9AB8-40FB-9FDF-BEBF74F004F7 Q36248048-3D61677A-CDC8-4D44-A39F-47709794041D Q38220769-77A67F39-EF3F-4321-BCD7-BE09FC48F263 Q38222245-996EFCB1-2D39-4418-8213-5E4D257C18D2 Q41830012-F46BE3E7-132F-476C-A40A-E49E5F9AE620 Q47837094-03EBEEA6-DBCC-4E06-9C9E-FBCDB7FBA9F6

P2860

Personalized medicine: applying 'omics' to lung fibrosis

http://www.wikidata.org/entity/Q26866919

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Personalized medicine: applying 'omics' to lung fibrosis

@ast

Personalized medicine: applying 'omics' to lung fibrosis

@en

Personalized medicine: applying 'omics' to lung fibrosis

@nl

type

label

Personalized medicine: applying 'omics' to lung fibrosis

@ast

Personalized medicine: applying 'omics' to lung fibrosis

@en

Personalized medicine: applying 'omics' to lung fibrosis

@nl

prefLabel

Personalized medicine: applying 'omics' to lung fibrosis

@ast

Personalized medicine: applying 'omics' to lung fibrosis

@en

Personalized medicine: applying 'omics' to lung fibrosis

@nl

P1433

Q26866919-4F2F97BE-55AD-4ED0-ADCD-BB5BCD00EC67

P1476

Q26866919-EF717DD1-926E-4A21-8900-D2F1B52B1778

P2093

Q26866919-128F3A5E-EA50-4058-8153-C5FEB9134BC4

P2860

Q26866919-034E935A-9A6B-4115-A573-A166FA4D2A67

Q26866919-07B821D4-EA72-44EE-9C3C-BBCE7E38D2DC

Q26866919-08704CCE-9169-4413-A157-31F3A15D46B5

Q26866919-0C9F4EDE-53D3-436C-8F96-922CA8E46412

Q26866919-0EDC164A-14DF-4A7A-A8A7-DFC2122453EB

Q26866919-0EE8AE9B-2A8D-4577-A29C-BFAB5F4285CB

Q26866919-1419F0D9-FA30-428F-89DF-EF36409D7DD9

Q26866919-154B9236-A31F-4613-AC77-5BB8ABFE9AA2

Q26866919-1A232D59-1986-4DCA-B9E5-037367306FEF

Q26866919-1AF3DA00-4376-4514-9A25-C2C52E3EF64C

P304

Q26866919-E1810024-DA5A-4619-BF03-D44C52C0711B

P31

Q26866919-DD922220-116D-444F-9085-9A0F317A7C90

P356

Q26866919-EAF368AB-86DD-46FD-9165-49D57E76ABCC

P407

Q26866919-4AC807A9-3773-4010-8528-CB7A6D7D87DE

P433

Q26866919-C6567FCF-8B1D-4823-BD3C-C532CF17789D

P478

Q26866919-FA71E5B2-3ABC-4B13-883A-5722AA2EF77D

P50

Q26866919-38840B2E-29AD-439B-9D0C-653B96806577

P577

Q26866919-ACE01C83-923E-431A-B1E1-415FD4B6E418

P5875

Q26866919-27125DED-D169-43E8-A2EE-3406390ABFAF

P698

Q26866919-459D300F-2275-4473-9129-89205B0E4FF0

P921

Q26866919-516DAFA0-0535-4EDA-B4F3-33B6CE7D1889

P932

Q26866919-543DED8A-BCB9-4C97-A18E-45A3CE3292CC

P356

P1433

Biomarkers in Medicine

P1476

Personalized medicine: applying 'omics' to lung fibrosis

@en

P2093

Jose D Herazo-Maya

http://www.w3.org/2001/XMLSchema#string

P2860

WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis

Inhibition and role of let-7d in idiopathic pulmonary fibrosis

Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis

WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis

Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis

Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis

Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes

Antimicrobial peptides of multicellular organisms

A mutation in the surfactant protein C gene associated with familial interstitial lung disease

P304

529-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.12.38

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Naftali Kaminski

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230732005

http://www.w3.org/2001/XMLSchema#string

P698

22917154

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

3517740

http://www.w3.org/2001/XMLSchema#string